{
  "id": 18506961,
  "title": "A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial",
  "url": "https://urgent.news/2026/11/06/a-kill-switch-for-epilepsy-china-cuts-seizures-by-92-6-in-first-human-18506961",
  "topic": "world",
  "section": "World",
  "published": "2026-11-06T13:00:08.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/news/china/science/article/3373500/kill-switch-epilepsy-china-cuts-seizures-926-first-human-chemogenetic-trial"
  },
  "original_language": "en",
  "account": null,
  "summary": "For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic. Around one-third of epilepsy patients worldwide are completely unresponsive to existing medications,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}